Breaking News

Kaiser invests $50M in fighting food insecurity

Not rendering correctly? View this email as a web page here.

AstraZeneca throws lifeline to gene-editing biotech LogicBio with $68M buyout

By Frank Vinluan Monday, October 3, 2022 8:09 PM

AstraZeneca's LogicBio acquisition comes at a critical time for the biotech. Though LogicBio has encouraging early clinical data for its lead gene-editing therapeutic candidate, the company's cash woes include a flagging stock price that is set to lose its listing on the Nasdaq.

Read more »

Leica, Philips come out on top in digital pathology systems market, KLAS finds

By Katie Adams Monday, October 3, 2022 6:51 PM

The digital pathology market is poised for rapid growth in the U.S., with several vendors vying for dominance. The imaging management systems made by Leica Biosystems and Philips seem to be leading the pack in this competitive market, according to a new report.

Read more »

Chronic loneliness is killing people: The solution is personal

By Ellen Rudy Monday, October 3, 2022 6:02 PM

In order to make an impact and improve physical and mental health, we need to recognize the need to approach loneliness as a condition. Building connections through social intervention is the most direct way to affect change.

Read more »

Report: 43% of working-age adults are inadequately insured

By Marissa Plescia Monday, October 3, 2022 5:56 PM

Of people who were found inadequately insured, 9% were uninsured, 11% had a period without coverage over the past year and 23% had coverage all year but were underinsured, the Commonwealth Fund report showed.

Read more »

Cala Health's real-world study validates its wearable's long-term efficacy

By Katie Adams Monday, October 3, 2022 2:55 PM

Cala Health recently published a post-market study showing that its wrist-based wearable to treat essential tremor effectively reduced patients' tremor power with no loss of effect over time. Most patients involved in the study reported improvement in daily activities, such as eating, drinking, texting and writing.

Read more »

FDA approves Taiho drug for rare bile duct cancer with certain genetic signature

By Frank Vinluan Monday, October 3, 2022 2:40 PM

Taiho Oncology's cancer drug Lytgobi is the third FDA-approved therapy for bile duct cancer driven by FGFR2 genetic alterations. The accelerated approval for Taiho's drug follows regulatory nods for products from Incyte and QED Therapeutics that address the same genetic signature.

Read more »

Helping seniors avoid the pitfalls of prescription overload

By Marc Rothman Monday, October 3, 2022 12:44 PM

Connecting vital, underutilized services like medication reviews to the daily lives and routines of older adults is the logical next step in the movement of care to the home

Read more »

   

No comments